A new report brings welcome news to patients with type 1 diabetes that an artificial pancreas that continuously monitors blood glucose levels and delivers insulin to the body as and when needed could be available in the next 2 years. Researchers say it is possible the artificial pancreas could be approved to treat type 1 diabetes as early as next year. Type 1 diabetes is estimated to affect around 1.25 million children and adults in the United States.

The condition arises when the beta cells of the pancreas stop producing insulin - the hormone that is responsible for removing glucose from the blood and transporting it to cells, where it is used for energy. Type 1 diabetes is estimated to affect around 1.25 million children and adults in the United States. The condition arises when the beta cells of the pancreas stop producing insulin - the hormone that is responsible for removing…